We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FTC COULD FOCUS ON AUTHORIZED GENERICS, EXPERTS SAY
FTC COULD FOCUS ON AUTHORIZED GENERICS, EXPERTS SAY
January 13, 2004
The increasing number of so-called “authorized generics” coming to market could attract the attention of federal antitrust regulators, according to pharmaceutical industry experts.